Literature DB >> 8868101

Oncogenic signaling.

C L Jones1, M A Kane.   

Abstract

Cancer develops when one or more cells begin to grow uncontrollably, presumably as a result of alterations in the highly regulated processes of normal cell division. These changes may result from germline or somatic mutations in genes that control normal cell proliferation, resulting in oncogenes. Oncogenes--originally defined as viral genes that transformed mammalian host cells--code for proteins with diverse functions. Antioncogenes, or tumor-suppressor genes, code for proteins acting as brakes in the cell cycle. Mutations in or deletions of these genes release the brakes. An overview of cellular signaling pathways, how they may be altered in cancers, and recently reported clinical implications of abnormal expression of some oncogenes and tumor-suppressor genes will be presented here.

Entities:  

Mesh:

Year:  1996        PMID: 8868101     DOI: 10.1097/00001622-199601000-00010

Source DB:  PubMed          Journal:  Curr Opin Oncol        ISSN: 1040-8746            Impact factor:   3.645


  4 in total

Review 1.  Breast cancer therapies in development. A review of their pharmacology and clinical potential.

Authors:  D de Valeriola; A Awada; J A Roy; A Di Leo; L Biganzoli; M Piccart
Journal:  Drugs       Date:  1997-09       Impact factor: 9.546

2.  Additive antisense effects of different PNAs on the in vitro translation of the PML/RARalpha gene.

Authors:  L Mologni; P leCoutre; P E Nielsen; C Gambacorti-Passerini
Journal:  Nucleic Acids Res       Date:  1998-04-15       Impact factor: 16.971

3.  A role for the putative tumor suppressor Bin1 in muscle cell differentiation.

Authors:  R J Wechsler-Reya; K J Elliott; G C Prendergast
Journal:  Mol Cell Biol       Date:  1998-01       Impact factor: 4.272

4.  Improvement of a method to reproducibly immortalize human T cells by oncogene transfection.

Authors:  S Alam; Y Katakura; H Yoshida; E H Kim; S Shirahata
Journal:  Cytotechnology       Date:  2000-07       Impact factor: 2.058

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.